baber/WOPTO huggingface dataset:
Patent NZ-565180-A (NZ)
Title: Pregabalin derivatives for the treatment of fibromyalgia and other disorders
Inventor: DOOLEY DAVID JAMES
Filed: 2003-12-03
Abstract: Disclosed is the use of certain alpha2alpha ligands for the treatment of fibromyalgia and other central nervous system disorders. In particular the use of (3S,5R)-3-Aminomethyl-5-methyl-octanoic acid, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for treating fibromyalgia, abdominal or gynaecological pain, and pain caused by increased bladder contractions in a mammal, including a human.
Patent NZ-573058-A (NZ)
Title: Sonar with two symmetrically mounted off axis antennas using mutually reversed Rx and Tx frequencies
Inventor: KOPP LAURENT
IPC: G01S15/93
Filed: 2007-04-26
Abstract: A multibeam sounder placed on a marine or submarine platform is disclosed. The sounder comprises two transmit/receive antennas (1, 10), the respective axes of which are off-aimed to the front, in the direction of movement of the platform and are symmetrical with respect to a straight line (3) passing through their intersection and parallel to the direction of advance of the platform. The transmit frequency of the first antenna is equal to the receive frequency of the second which is different from the transmit frequency of the second, this latter frequency being equal to the receive frequency of the first antenna. This arrangement makes it possible to anticipate obstacles and objects of interest, such as fixed obstacles or shoals of fish, which the platform may encounter on its route.
Patent NZ-573874-A (NZ)
Title: Method and apparatus to generate thrust by inertial mass variance
Inventor: STEPHENS MALCOLM B
IPC: B64G1/40
Filed: 2007-06-15
Abstract: A device for inducing inertial mass change in an object, comprises a mass change object 30 with a mass change region configured to have time-varying power with a non-zero time rate of change. A vacuum is located in the region. A power source is configured to produce the time-varying power located at the mass change region. An accelerator to accelerate the mass change object 30 with time varying power is located in the mass change region.
Patent NZ-573964-A (NZ)
Title: isopropyl [3-({[4-(1H-pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)-amino}methyl)phenoxy]acetate, a prostaglandin E2 receptor agonist (EP2), useful in lower intraocular pressure thereby treating glaucoma
Inventor: PRASANNA GANESH
IPC: A61K31/4155
Filed: 2007-07-16
Abstract: Disclosed herein is isopropyl [3-({[4-(1H-pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)-amino}methyl)phenoxy]acetate represented by the formula shown herein, a prostaglandin E2 agonist (EP2), which is useful for reducing intraocular pressure and thereby treating glaucoma.
Patent NZ-578278-A (NZ)
Title: Gyratory crusher having first and second crushing shells and liquid cushion
Inventor: NORRMAN PERCY
IPC: B02C2/04
Filed: 2008-02-01
Abstract: A gyratory crusher comprises a crushing head (12) on which a first crushing shell (16) is mounted, and a frame on which a second crushing shell (18) is mounted. The second crushing shell defines, together with the first crushing shell, a crushing gap. The gyratory crusher comprises a space (22) adapted to hold a liquid. The space is defined by a piston (2) and a cylinder (24), either of which is formed at least partly of a substantially vertical shaft around which the crushing head is arranged. The space is adapted to form, together with the liquid, a cushion (23). The cushion serves as a thrust bearing to transmit vertical forces from the crushing head to the frame.
Patent NZ-580416-A (NZ)
Title: Method and apparatus for minimising the demand on the vacuum system of a milking system during its cleaning cycle
Inventor: HARTY EDMOND PATRICK JUNIOR
IPC: A01J7/02
Filed: 2008-04-28
Abstract: A method for minimising the power requirement of a vacuum system of a vacuum operated milking system and an apparatus for operating a vacuum operated milking system for minimising the power requirement of the milking system are disclosed. The apparatus comprises a control means (60) for operating the milking system with the vacuum demand by a pulsating vacuum generator thereof reduced. The control means is responsive to the milking system being operated in a cleaning cycle for operating the milking system with the vacuum demand by the pulsating vacuum generator reduced for a time period during at least a portion of a cleaning cycle, at least while the vacuum demand by the milking system is greatest. Also disclosed is a vacuum operated milking system (1) operable in a milking mode and a cleaning mode, and in the cleaning mode the milking system is operable in a cleaning cycle. The milking system comprises a main milk pipeline (2) extending between an upstream end (3) and a downstream end (4) and terminating at the downstream end in a receiving means (5), a plurality of milking clusters (9) coupled to the main milk pipeline at spaced apart intervals between the upstream end and the downstream end thereof, a vacuum system (8) coupled to the main milk pipeline through the receiving means for applying a vacuum to the milking clusters for drawing milk from the milking clusters through the main milk pipeline to the receiving means, a pulsating vacuum generator (24) coupled to the vacuum system for applying a pulsating vacuum to the milking clusters, and the above described control means for selectively operating the milking system with the vacuum demand by the pulsating vacuum generator reduced.
Patent NZ-580955-A (NZ)
Title: Process for preparing valsartan
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: C07D257/04
Filed: 2008-05-07
Abstract: Disclosed is a N-[(2´-(1-triphenyl methyl tetrazole-5-yl)biphenyl]-4-yl]methyl]-L-valinebenzyl ester organic salt of formula (IVA), wherein A is an organic carboxylic acid. Processes for making the compound of formula (IVA) are disclosed. A process for making Valsartan using the compound of formula (IVA) is also disclosed.
Patent NZ-582147-A (NZ)
Title: Improved structural sandwich plate members
Inventor: KENNEDY STEPHEN JOHN
IPC: B32B15/08
Filed: 2005-12-21
Abstract: A method of manufacturing structural sandwich plates, by preparing an outer plate 12 and attaching perimeter bars 14 to it with adhesive. A second outer plate 11 is then attached to the top of the perimeter bars 14 with adhesive. Plastics or polymer material is then injected into the cavity thus formed and cured. After this the process is completed by welding the outer plates to the perimeter bars. Shear forces are transferred between the outer plates by the core thus formed. (62) Divided Out of 555695
Patent NZ-586785-A (NZ)
Title: Inserter assembly with means for accelerating the penetrating member
Inventor: HORDUM ELO LAU
IPC: A61M5/142
Filed: 2009-02-06
Abstract: Disclosed is an assembly suitable for inserting penetrating member into the subcutaneous or intramuscular area of a patient. The device includes an inserter device (10), a penetrating member and a base part. The base part comprises a surface adapted to be attached to a skin surface, a position adapted to receive and/or attach to the penetrating member, and means adapted to secure the base part to the inserter device. The penetrating member comprises a part to be placed subcutaneously or intramuscularly, a body which is in contact with the inserter device during insertion and with the base part during use. The inserter device comprises a cavity for receiving the penetrating member, means for accelerating the penetrating member and bringing the penetrating member to the receiving position in the base part and means for penetrating the skin of the patient. The length of the joined assembly before use is larger than the length of the base part alone.
Patent NZ-595548-A (NZ)
Title: Polyolefin stabilizer compositions comprising a hindered arylalkyl phosphite, a trisarylphosphite and a hindered phenol
Inventor: ZENNER JOHN MATHEW
IPC: C07F9/06
Filed: 2007-05-10
Abstract: 595548 Disclosed is a composition for stabilising polyolefins which comprises: (a) a hindered arylalkyl phosphite compound according to formula (I) (such as bis-(2,6-di-t-butyl-4-methylphenyl) pentaerythritol diphosphite); (b) a trisarylphosphite of the formula (III) (such as tris-(2,4-di-t-butylphenyl) phosphite, tris(4-nonylphenyl phosphite or triphenyl phosphite); and (c) a hindered phenol comprising a molecular fragment selected from the formulae (IVa), (IVb) or (IVc) (such as 1,3,5-tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione or triethylene glycol bis[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionate]); wherein the substituents are as defined herein.
Patent NZ-596602-A (NZ)
Title: Oxazolidinone containing dimer compounds, compositions and methods to make and use
Inventor: HESTER D KEITH
IPC: A61K31/675
Filed: 2010-05-27
Abstract: 596602 Disclosed are phosphate-containing dimers of (5R)-3-[3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-(hydroxymethyl)-2-oxazolidinone, having antibiotic activity in vivo upon cleaving, wherein M is OR1; wherein R1 is H, or a pharmaceutically acceptable cation. Also disclosed are methods for the synthesis of such compounds and also the use of such for treating or preventing an bacterial infection.
Patent NZ-599188-A (NZ)
Title: A composite insulating panel
Inventor: CAROLAN JAMES
IPC: E04D3/35
Filed: 2010-11-04
Abstract: A photovoltaic solar collector (10) is mounted to a profiled external sheet (2) of an underlying composite insulating panel. The solar collector (10) comprises a photovoltaic sheet (20) and a protective translucent cover (21) for the photovoltaic sheet (20). A first adhesive layer (22) is provided between the photovoltaic sheet (20) and the translucent cover (21). A second adhesive layer (23) is provided between the underside of the photovoltaic sheet (20) and the external surface of the composite panel upper or external sheet (2). The adhesive layers (22), (23) may be of the same hot melt adhesive. In the invention sheets of the photovoltaic (20), the adhesive (22), (23), and the cover (21) are drawn from supply reels, are cut to length, and then laid on top of the upper sheet (2) of the insulated panel. Using a pressure laminating process the various layers are heated and pressed to adhere to and conform to the outer sheet 2 of the insulated panel. The external sheet comprises a number of longitudinally extending profile ribs and the photo voltaic sheet follows the contours of the ribs.
Patent NZ-600382-A (NZ)
Title: Modified bovine G-CSF polypeptides and their uses
Inventor: HAYS PUTNAM ANNA-MARIA A
IPC: A61K38/00
Filed: 2009-07-22
Abstract: 600382 Discloses a bG-CSF polypeptide comprising a non-naturally encoded amino acid substituted at position 133 of SEQ ID NO: 1 or the corresponding amino acid in SEQ ID NO: 2, where the non-naturally encoded amino acid is reactive toward a linker, polymer or biologically active molecule. Where the non-naturally encoded amino acid comprises carbonyl group, an aminooxy group, a hydrazine group, a hydrazide group, a semicarbazine group, an azide group or an alkyne group but where the amino acid is no para-acetylphenylalanine.
Patent NZ-605078-A (NZ)
Title: Flame retardant polymer composites, fibers, carpets, and methods of making each
Inventor: WILLIAMS FRANKLIN PIERCE
IPC: C08K3/00
Filed: 2009-08-13
Abstract: Disclosed herein are flame retardant polymer composites, processes for the preparation of the polymer composite, and application of the polymer composites in fibers and fabrics. The flame retardant composite, comprises: a polyamide, an organoclay composition (which may be a mineral clay selected from: hectorite, montmorillonite, bentonite, beidelite, saponite, stevensite, and mixtures thereof), and an inorganic bromine compound (preferably from: KBr, NaBr, RbBr, and LiBr); wherein the inorganic bromine compound is not antimony bromide.
Patent NZ-615639-A (NZ)
Title: Composition containing scirpusin b, and process for producing composition containing scirpusin b
Inventor: SANO SHOKO
IPC: A23L19/00
Filed: 2011-04-22
Abstract: Provided is a composition comprising scirpusin B, depicted in formula (1), characterised in that the scirpusin B is extracted from passion fruit seeds. Scirpusin B is a dimer of piceatannol. Further provided is a process for preparing the composition. In a preferred embodiment scirpusin B is obtained from passion fruit seeds by adding hydrous ethanol to the seeds and heating to reflux. Also provided is a foodstuff, beverage or cosmetic preparation comprising the composition.
Patent NZ-621902-A (NZ)
Title: Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
Inventor: LAU KELBY
IPC: C07K16/28
Filed: 2012-08-31
Abstract: An ultrafiltration method for preparing a highly concentrated antibody or protein composition is disclosed. The concentration of antibodies or the proteins in the composition is at least 200 g/L. The method comprises 1) providing an initial antibody or protein preparation, having an antibody or protein concentration of less than 200 g/L; 2) regulating the feed flow rate of the initial antibody or protein preparation to allow the value of feed pressure applied to an ultrafiltration membrane to increase to 85-100% of a specified maximum feed pressure of an ultrafiltration membrane where the feed flow rate is maintained at 200 LMH (L/m2 /hour) or higher; and 3) decreasing the feed flow rate to maintain or decrease the value of the feed pressure applied to the ultrafiltration membrane after step (2).
Patent NZ-623724-A (NZ)
Title: Vegf/dll4 binding agents and uses thereof
Inventor: GURNEY AUSTIN L
IPC: C12P21/08
Filed: 2012-09-24
Abstract: Disclosed is a bispecific antibody comprising: a) a first antigen-binding site that specifically binds human vascular endothelial growth factor (VEGF), and b) a second antigen-binding site that specifically binds human delta-like 4 ligand (DLL4), comprising the CDRs of the sequences as defined in the specification. Also disclosed is its use in treating cancer.
Patent NZ-629669-A (NZ)
Title: A nozzle
Inventor: MICHAEL SEAN JOYNT
IPC: B08B3/04
Filed: 2013-09-23
Abstract: A nozzle able to attach to a pressurised water supply hose that is able to modify and aerate the water flow prior to exiting the nozzle is disclosed. The fluid flow control nozzle (100) includes a body (100) having a pressurised fluid inlet (1) to allow a pressurised fluid to pass into the body and an outlet (2) for the pressured fluid to exit the body. The body defines at least one passage between the inlet and outlet for the pressured fluid to pass. To allow the flow rate of the pressurised fluid that exists in the body to be varied or stopped the body provides a pressurised fluid flow control valve (202). An ambient air inlet passage (301) draws, by way of a venturi effect established with the pressurised fluid flow through the at least one passage, ambient air into the pressurised fluid flow prior to the pressurised fluid exiting the outlet. Embodiments may also have means to vary the air flow. High velocity hoses are used widely in the dairy farming industry to wash contamination from milking shed floors. However other uses of high velocity water hoses are well known. As well as high velocity, high flow rate is also used, as the more water leaving the hose equates to more power to move matter/contaminates on the floor to be washed. Due to the large flow rate of these hoses in these areas, a lot of water is used. Often they are used by businesses for wash down multiple times per day. In which case, a need arises to reduce the amount of water being used in each wash down, whilst still being able to keep the matter moving power of the water. The nozzle increases the volume of the flow of water with air. This is useful for industrial applications where large volumes of water are used. In particular but not solely to wash down/clean areas. The air volumised flow helps reduce water consumption whilst not adversely affecting washdown time and effectiveness.
Patent NZ-630435-A (NZ)
Title: Crystalline forms of an hcv inhibitor
Inventor: BRACKEMEYER PAUL J
IPC: C07D487/04
Filed: 2013-07-11
Abstract: Disclosed are crystalline forms of compound I (Paritaprevir) after equilibration at 43% relative humidity with characteristic peaks in the PXRD pattern at values of two theta (°2θ) of 10.7, 11.6, 12.7, 13.0, 13.2, 13.7, 14.5, 18.7, 19.0, and 19.9. Also disclosed is a process for making a crystalline form of compound I with seed crystals The compound of formula I is: (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide
Patent NZ-706481-A (NZ)
Title: Modified polyphenol binder compositions and methods for making and using same
Inventor: HAGIOPOL CORNEL
IPC: C08L29/10
Filed: 2013-10-01
Abstract: Modified polyphenol binder compositions and methods for making and using same are provided. Such embodiments relate to modified polyphenol binder compositions for making composite lignocellulose containing products. Conventional binders used in the production of these products frequently contain formaldehyde based resins. These formaldehyde based resins, however, release formaldehyde into the environment during the production of the binder, curing of the binder/lignocellulose containing product, as well as, from the final product made using the formaldehyde based binder. The present invention provides improved binder compositions for making composite lignocellulose containing products having reduced or no formaldehyde emission. In some embodiments, the binder composition can include at least one unsaturated monomer, a tannin, and at least one polyphenolic compound that can include a lignin, a novolac resin, a modified phenol formaldehyde resin, bis-phenol A, humic acid, or any mixture thereof. The binder composition can include about 0.1 wt% to about 1 wt% of the unsaturated monomer, based on a solids weight of the tannin and the at least one polyphenolic compound. In other embodiments, the binder composition can include a reaction product of an unsaturated monomer and at least two polyphenolic compounds selected from the group consisting of: a tannin, a lignin, a novolac resin, a modified phenol formaldehyde resin, bis-phenol A, and humic acid. The binder composition can include about 0.05 wt% to 10 wt% of the unsaturated monomer, based on a solids weight of the at least two polyphenolic compounds. The unsaturated monomer is selected from an unsaturated glycidyl ether, an unsaturated glycidyl ester, an unsaturated mono-epoxide, an unsaturated methylol compound, maleic anhydride, or any mixture thereof.
Patent NZ-719328-A (NZ)
Title: Nicotinamide riboside compositions for topical use in treating skin conditions
Inventor: DEREN-LEWIS ANN
IPC: C07H19/048
Filed: 2014-10-30
Abstract: Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof. In a particular embodiments of the invention, it is a topical composition comprising nicotinamide riboside for treating skin conditions relating to UV (ultra-violet) mediated DNA damage, oxidative stress or wound healing.
Patent NZ-721526-A (NZ)
Title: Black tea beverage
Inventor: SATO TOSHIYA
IPC: A23F3/16
Filed: 2014-12-10
Abstract: Provided is a black tea beverage having an excellent sweet and sour taste and high freshness. The black tea beverage contains 5-50 mg/100 ml of tannin and has a ratio of the total amount by mass of ethyl butyrate, ethyl 2-methylbutyrate, butyl acetate and 2-methylbutyl acetate to the mass of ethyl hexanoate, in the whole beverage, of 100 or higher. The black tea beverage preferably contains 10 mass% or more of a fruit juice relative to the total mass of the beverage. It is further preferred that the fruit juice contained therein is an apple juice.
Patent NZ-723782-A (NZ)
Title: A yarn comprising gel-forming filaments or fibres
Inventor: BONNEFIN WAYNE
IPC: D06M23/10
Filed: 2012-11-29
Abstract: A process for making a fabric structure, the process comprising the steps of: (i) obtaining a yarn of cellulosic filaments or fibres; (ii) chemically modifying the yarn to give the yarn gel forming properties; and (iii) knitting or weaving the chemically modified yarn to produce the fabric structure. The chemically modified yarn comprises from 50% to 100% by weight gel-forming fibres, and has a dry tensile strength of at least 10 cN/tex.
Patent NZ-724074-A (NZ)
Title: Locking pivot mechanism for a portable clothes line
Inventor: DAOYUAN WANG
IPC: A47C4/22
Filed: 2016-09-07
Abstract: Locking mechanisms for pivots have been developed, however known examples are often difficult to use. Typical locks require the user to slide a lever or push a button whilst simultaneously moving the legs. Often a great deal of force is required to move the locking mechanism from the locked position to the unlocked position which can be troublesome for the aged or infirm. Some locking mechanisms can be unlocked and then the legs subsequently moved. The present invention teaches a locking pivot mechanism for a portable clothes line comprising a fixed latch with slots and a pivotally mounted latch housing including a spring mounted roller for engaging the slots. When the roller engages either of the slots the mechanism is prevented from pivoting. A lateral force applied to the housing can dislodge the roller from a slot thereby allowing the mechanism to pivot.
Patent NZ-725766-A (NZ)
Title: System and method for assessing animals considering auscultation and evaluation of physiological responses in various environments
Inventor: BRATTAIN KURT
IPC: A61B5/024
Filed: 2015-04-29
Abstract: The invention includes a system and method for predicting the performance of production animals by analysis of heart and lung sounds to determine likelihoods the animals will develop BRD or other diseases or ailments. Vital signs of animals are recorded during an adrenergic sympathetic “flight or fight” situation. A cardio-pulmonary rate ratio is determined for each animal by dividing a normalized adjusted heart rate value by a normalized adjusted respiratory value. From the ratios calculated for each animal in a group, a ratio range is established. Ratio values at a lower end of the ratio range indicate higher relative respiration rates and poor lung performance due to disease. Ratio values at an upper end of the range may indicate low cardiac output and an inability to tolerate rapid weight gain. Ratio values at either end of the range may indicate compromised cardio- pulmonary function. Animals can be further classified by weight, and the ratio values within weight classes are used to generate probabilities for BRD or other diseases.
Patent NZ-730808-A (NZ)
Title: Immunoregulatory agents
Inventor: BECK HILARY PLAKE
IPC: A61K31/4375
Filed: 2015-11-05
Abstract: The invention relates to the compound (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide, stereoisomers and pharmaceutically acceptable salts thereof, and compositions containing these compounds. These compounds modulate the oxidoreductase enzyme indoleamine 2,3- dioxygenase. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.